Larimar Therapeutics, Inc.
LRMR
Positions held
Your positionsLRMR isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $280.48M | Enterprise value | $130.52M | Trailing P/E | — | Forward P/E | -2.55 |
| PEG | — | Price / book | 2.21 | Beta | 0.69 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -139.6% | ROA | -71.0% | Debt / equity | 0.04 |
| Current ratio | 4.70 | Free cash flow | -$94.18M | Analyst recommendation | strong_buy | Mean target | $14.40 |
| 52w high | $6.42 | 52w low | $2.61 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$32.8M | -$29.6M | -$62.5M | -$47.7M | -$26.2M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$34.4M | -$31.1M | -$64.0M | -$49.5M | -$27.8M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$166M | -$80.6M | -$36.9M | -$35.4M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$172M | -$90.9M | -$41.8M | -$36.5M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2026-09-29 · Larimar Therapeutics Names John Harlow COO
2026-09-14 · 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-09 · Century Therapeutics Appoints Joseph Truitt to Board of Directors
2026-08-04 · Larimar: Q2 Earnings Snapshot
2026-08-04 · Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
2026-07-15 · Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy
Price (daily)
Full chart · RSI · MACD · patterns